Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery

British Journal of Pharmacology
G R Drummond, T M Cocks

Abstract

1. Rings of bovine left anterior descending coronary artery (LAD) were contracted with the thromboxane A2-mimetic, U46619 (1-30 nM), to approximately 40% of their maximum contraction to 125 mM KCl Krebs solution (KPSSmax) for comparison of responses to the B1 and B2 kinin receptor agonists, des-Arg9-bradykinin (des-Arg9-BK) and bradykinin (BK), respectively. Relaxation responses were normalized as percentages of the initial U46619-induced contraction level, while contractile responses were expressed as percentages of KPSSmax. 2. After 6 h of in vitro incubation in Krebs solution at 37 degrees C, des-Arg9-BK (pEC50, 8.00 +/- 0.08; maximum response (Rmax), 93.9 +/- 1.9%) and BK (pEC50, 9.75 +/- 0.07; Rmax, 100.1 +/- 0.7%) caused endothelium-dependent relaxations in precontracted rings of bovine LAD which were competitively and selectively antagonized by the B1 receptor antagonist, des-Arg9-[Leu8]-BK (pA2, 6.27 +/- 0.11) and the B2 receptor antagonist Hoc-140 (pA2, 9.63 +/- 0.14), respectively. 3. At 3 h of in vitro incubation, the sensitivity (pEC50, 7.45 +/- 0.10) and Rmax (84.6 +/- 3.3%) to des-Arg9-BK were significantly less than those obtained in the same tissues at 6 h (pEC50, 7.94 +/- 0.06; Rmax, 91.4 +/- 2.5%), whereas end...Continue Reading

References

Aug 1, 1978·Canadian Journal of Physiology and Pharmacology·D RegoliJ Barabé
Aug 1, 1977·Canadian Journal of Physiology and Pharmacology·D RegoliW K Park
Sep 30, 1992·Biochemical and Biophysical Research Communications·D EggerickxM Parmentier
Mar 1, 1991·British Journal of Pharmacology·F J HockJ Knolle
Apr 10, 1991·European Journal of Pharmacology·J Staszewska-Woolley, O L Woodman
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A E McEachernK Jarnagin
Apr 9, 1986·European Journal of Pharmacology·D RegoliJ Barabé
Oct 14, 1986·European Journal of Pharmacology·L Churchill, P E Ward
Apr 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·E T WhalleyR H Lye
Mar 31, 1987·European Journal of Pharmacology·N TodaT Okamura
Oct 1, 1987·British Journal of Pharmacology·J BouthillierF Marceau
Aug 7, 1985·European Journal of Pharmacology·P D'Orléans-JusteD Regoli
Dec 1, 1982·Canadian Journal of Physiology and Pharmacology·J BarabéD Regoli
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P D CherryD Jothianandan
Dec 1, 1982·Canadian Journal of Physiology and Pharmacology·D RegoliS Caranikas
Jan 1, 1995·Trends in Pharmacological Sciences·C J GarlandT M Cocks
Feb 15, 1994·European Journal of Pharmacology·K A SchneckR W Ransom
Aug 3, 1993·European Journal of Pharmacology·D Pruneau, P Bélichard
Jan 1, 1993·American Journal of Respiratory Cell and Molecular Biology·T Nagao, P M Vanhoutte
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD

❮ Previous
Next ❯

Citations

Jun 18, 2002·Journal of Cellular Physiology·B L Y CheukP Y D Wong
Jan 5, 2002·European Journal of Pharmacology·H NawaY Kurosaki
Aug 20, 1997·European Journal of Pharmacology·N BerthiaumeP D'Orléans-Juste
Jul 3, 1998·European Journal of Pharmacology·D RegoliF J Gobeil
Jun 1, 1997·Immunopharmacology·D RegoliF Gobeil
Feb 1, 1997·British Journal of Pharmacology·D EguchiH Kanaide
Apr 27, 1999·British Journal of Pharmacology·M TrevisaniP Geppetti
Jan 11, 2003·British Journal of Pharmacology·Rose Mari J ViannaRéjean Couture
Sep 10, 1998·Journal of Veterinary Pharmacology and Therapeutics·Y NakamuraA Nishio
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Masao KakokiOliver Smithies
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Masao KakokiOliver Smithies
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·J B PesqueroM Bader
Sep 14, 2007·Scandinavian Cardiovascular Journal : SCJ·Jozefa DabekAndrzej Kulach
Feb 10, 2012·Kidney International·Hirofumi TomitaMasao Kakoki
Feb 5, 2009·Kidney International·Masao Kakoki, Oliver Smithies
Jan 16, 2016·The Journal of Pharmacology and Experimental Therapeutics·Yael KilsteinRodolfo Pedro Rothlin
Sep 27, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Amar S MoreDongmei Wu
Jul 1, 1999·Clinical and Experimental Pharmacology & Physiology·M Tsukada, S Chiba
Oct 15, 2003·Hypertension·Irena DukaHaralambos Gavras
Mar 2, 2006·American Journal of Physiology. Endocrinology and Metabolism·Arvi DukaHaralambos Gavras
Oct 6, 2001·Journal of Cardiovascular Pharmacology·M SzekeresA Koller
Feb 7, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N L'HeureuxR Andriantsitohaina
Nov 18, 2000·Journal of Neuropathology and Experimental Neurology·A PratJ P Antel
Jun 14, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Francis A SylvesterJulian H Lombard

❮ Previous
Next ❯

Related Concepts

Related Feeds

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.